Shariah compliance overview
HalalAcadia Pharmaceuticals Inc. (ACAD) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders.
Acadia Pharmaceuticals Inc. (ACAD) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.88% (limit 5%), interest-bearing debt is 0.33% (limit 30%) and interest-bearing securities and assets are 23.14% (limit 30%).
If you hold ACAD, give 2.88% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 2.88%Limit 5%Pass
- Interest-bearing debt
- 0.33%Limit 30%Pass
- Interest-bearing securities and assets
- 23.14%Limit 30%Pass
- Dividend purification
- 2.88%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Acadia Pharmaceuticals Inc. (ACAD). Current Akinda screening label: Halal.
